Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors

Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors

Urticarial eruptions and angioedema are the most common cutaneous reactions in patients undergoing mRNA COVID-19 vaccinations. The vasoactive peptide bradykinin has long been known to be involved in angioedema and recently also in urticaria. Bradykinin is mainly catabolized by angiotensin-converting...

Full description

Bibliographic Details
Main Authors: Massimo Cugno, Dario Consonni, Andrea Lombardi, Patrizia Bono, Massimo Oggioni, Sara Uceda Renteria, Angela Cecilia Pesatori, Silvana Castaldi, Luciano Riboldi, Lorenzo Bordini, Carlo Domenico Nava, Ferruccio Ceriotti, Adriana Torri, Francesco Tafuri, Gabriele Ghigliazza, Flora Peyvandi, Alessandra Bandera, Andrea Gori
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Vaccines
Subjects:
angioedema
urticaria
COVID-19 vaccination
mRNA vaccination
ACE inhibitors
heath care workers
Online Access:https://www.mdpi.com/2076-393X/9/9/1011

Internet

https://www.mdpi.com/2076-393X/9/9/1011

Similar Items